

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 7.64236244 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 7.64236244 |
| 3 | endocrine pancreas development (GO:0031018) | 5.26189933 |
| 4 | protein maturation by protein folding (GO:0022417) | 5.04732622 |
| 5 | peptide hormone processing (GO:0016486) | 4.98796956 |
| 6 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.91154021 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.87892799 |
| 8 | insulin secretion (GO:0030073) | 4.87691837 |
| 9 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.66539638 |
| 10 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.63674781 |
| 11 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.63493237 |
| 12 | dendritic spine morphogenesis (GO:0060997) | 4.53728337 |
| 13 | detection of calcium ion (GO:0005513) | 4.53541273 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.45280057 |
| 15 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.37916247 |
| 16 | type B pancreatic cell development (GO:0003323) | 4.33550333 |
| 17 | protein localization to synapse (GO:0035418) | 4.32648508 |
| 18 | vocalization behavior (GO:0071625) | 4.30150128 |
| 19 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.28172517 |
| 20 | neuron cell-cell adhesion (GO:0007158) | 4.26346740 |
| 21 | positive regulation of insulin secretion (GO:0032024) | 4.25818608 |
| 22 | glandular epithelial cell differentiation (GO:0002067) | 4.23641789 |
| 23 | postsynaptic membrane organization (GO:0001941) | 4.21647507 |
| 24 | COPII vesicle coating (GO:0048208) | 4.19698796 |
| 25 | cellular potassium ion homeostasis (GO:0030007) | 4.13731277 |
| 26 | synaptic vesicle maturation (GO:0016188) | 4.09375675 |
| 27 | regulation of insulin secretion (GO:0050796) | 4.08159548 |
| 28 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.04885686 |
| 29 | protein retention in ER lumen (GO:0006621) | 4.04619066 |
| 30 | glandular epithelial cell development (GO:0002068) | 3.92192400 |
| 31 | cerebellar Purkinje cell layer development (GO:0021680) | 3.91814514 |
| 32 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.88497424 |
| 33 | glutamate receptor signaling pathway (GO:0007215) | 3.83010162 |
| 34 | vesicle coating (GO:0006901) | 3.79355201 |
| 35 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.79124893 |
| 36 | presynaptic membrane assembly (GO:0097105) | 3.79057711 |
| 37 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.78336174 |
| 38 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.75441900 |
| 39 | synaptic vesicle exocytosis (GO:0016079) | 3.71722665 |
| 40 | regulation of peptide hormone secretion (GO:0090276) | 3.71573965 |
| 41 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.69653940 |
| 42 | synaptic transmission, glutamatergic (GO:0035249) | 3.69428944 |
| 43 | peptide hormone secretion (GO:0030072) | 3.69084194 |
| 44 | neurotransmitter transport (GO:0006836) | 3.67831366 |
| 45 | regulation of peptide secretion (GO:0002791) | 3.67324690 |
| 46 | neuron recognition (GO:0008038) | 3.66649545 |
| 47 | exocrine pancreas development (GO:0031017) | 3.65977232 |
| 48 | positive regulation of nuclease activity (GO:0032075) | 3.64839140 |
| 49 | auditory behavior (GO:0031223) | 3.62421708 |
| 50 | exploration behavior (GO:0035640) | 3.61736581 |
| 51 | axonal fasciculation (GO:0007413) | 3.59266007 |
| 52 | peptide secretion (GO:0002790) | 3.58885837 |
| 53 | chemosensory behavior (GO:0007635) | 3.58666746 |
| 54 | neuron-neuron synaptic transmission (GO:0007270) | 3.57674851 |
| 55 | nitric oxide mediated signal transduction (GO:0007263) | 3.57542484 |
| 56 | positive regulation of synapse maturation (GO:0090129) | 3.57029564 |
| 57 | regulation of synaptic vesicle transport (GO:1902803) | 3.53793642 |
| 58 | presynaptic membrane organization (GO:0097090) | 3.52493873 |
| 59 | positive regulation of peptide hormone secretion (GO:0090277) | 3.50049913 |
| 60 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.49423533 |
| 61 | nucleobase catabolic process (GO:0046113) | 3.49260054 |
| 62 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.48046487 |
| 63 | ER overload response (GO:0006983) | 3.47827988 |
| 64 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.46723272 |
| 65 | positive regulation of peptide secretion (GO:0002793) | 3.46140987 |
| 66 | membrane depolarization during action potential (GO:0086010) | 3.44874509 |
| 67 | transmission of nerve impulse (GO:0019226) | 3.43526808 |
| 68 | startle response (GO:0001964) | 3.42671267 |
| 69 | regulation of neurotransmitter levels (GO:0001505) | 3.42523613 |
| 70 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.41328757 |
| 71 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.41017026 |
| 72 | positive regulation of membrane potential (GO:0045838) | 3.40860577 |
| 73 | locomotory exploration behavior (GO:0035641) | 3.39612227 |
| 74 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.37149875 |
| 75 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.35612585 |
| 76 | negative regulation of catecholamine secretion (GO:0033604) | 3.34218253 |
| 77 | cellular response to glucagon stimulus (GO:0071377) | 3.33489536 |
| 78 | sodium ion export (GO:0071436) | 3.32449198 |
| 79 | regulation of synapse structural plasticity (GO:0051823) | 3.29287384 |
| 80 | regulation of nuclease activity (GO:0032069) | 3.28397901 |
| 81 | positive regulation of neurotransmitter transport (GO:0051590) | 3.27476625 |
| 82 | activation of protein kinase A activity (GO:0034199) | 3.24782992 |
| 83 | proline transport (GO:0015824) | 3.24401778 |
| 84 | gamma-aminobutyric acid transport (GO:0015812) | 3.23997679 |
| 85 | cerebellar granule cell differentiation (GO:0021707) | 3.23340849 |
| 86 | regulation of glucocorticoid secretion (GO:2000849) | 3.22985779 |
| 87 | regulation of hormone secretion (GO:0046883) | 3.22349759 |
| 88 | protein targeting to Golgi (GO:0000042) | 3.22104795 |
| 89 | regulation of postsynaptic membrane potential (GO:0060078) | 3.21771767 |
| 90 | layer formation in cerebral cortex (GO:0021819) | 3.21056032 |
| 91 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.20480237 |
| 92 | glutamate secretion (GO:0014047) | 3.18312189 |
| 93 | regulation of neurotransmitter secretion (GO:0046928) | 3.16663103 |
| 94 | negative regulation of norepinephrine secretion (GO:0010700) | 3.16383555 |
| 95 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.16324568 |
| 96 | neuronal ion channel clustering (GO:0045161) | 3.16125553 |
| 97 | sequestering of metal ion (GO:0051238) | 3.15944436 |
| 98 | inner ear receptor cell development (GO:0060119) | 3.15425434 |
| 99 | potassium ion homeostasis (GO:0055075) | 3.13301689 |
| 100 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.12885239 |
| 101 | synapse assembly (GO:0007416) | 3.12700669 |
| 102 | toxin metabolic process (GO:0009404) | 3.11876855 |
| 103 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.11850447 |
| 104 | positive regulation of exocytosis (GO:0045921) | 3.11824902 |
| 105 | response to dietary excess (GO:0002021) | 3.10241508 |
| 106 | dendrite morphogenesis (GO:0048813) | 3.10086361 |
| 107 | serotonin metabolic process (GO:0042428) | 3.10056891 |
| 108 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.09035874 |
| 109 | dendritic spine organization (GO:0097061) | 3.06109750 |
| 110 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.05513943 |
| 111 | cellular response to unfolded protein (GO:0034620) | 3.04936925 |
| 112 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.04354610 |
| 113 | response to auditory stimulus (GO:0010996) | 3.04220096 |
| 114 | neuronal action potential propagation (GO:0019227) | 3.01999783 |
| 115 | protein localization to Golgi apparatus (GO:0034067) | 2.99331530 |
| 116 | positive regulation of vesicle fusion (GO:0031340) | 2.98250479 |
| 117 | regulation of synapse maturation (GO:0090128) | 2.97811166 |
| 118 | regulation of peptide transport (GO:0090087) | 2.97742991 |
| 119 | membrane depolarization (GO:0051899) | 2.97712231 |
| 120 | regulation of neurotransmitter transport (GO:0051588) | 2.97061457 |
| 121 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.96863378 |
| 122 | cellular response to topologically incorrect protein (GO:0035967) | 2.96450970 |
| 123 | ER-nucleus signaling pathway (GO:0006984) | 2.96335952 |
| 124 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.95590574 |
| 125 | neurotransmitter secretion (GO:0007269) | 2.94726057 |
| 126 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.94360947 |
| 127 | response to pheromone (GO:0019236) | 2.92861439 |
| 128 | cell migration in hindbrain (GO:0021535) | 2.92617746 |
| 129 | synaptic vesicle endocytosis (GO:0048488) | 2.91639668 |
| 130 | innervation (GO:0060384) | 2.91129907 |
| 131 | negative regulation of insulin secretion (GO:0046676) | 2.91018460 |
| 132 | regulation of vesicle fusion (GO:0031338) | 2.90660714 |
| 133 | establishment of mitochondrion localization (GO:0051654) | 2.89508170 |
| 134 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.88141386 |
| 135 | regulation of exocytosis (GO:0017157) | 2.88084118 |
| 136 | synaptic transmission (GO:0007268) | 2.87447420 |
| 137 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.87257097 |
| 138 | signal release (GO:0023061) | 2.86677733 |
| 139 | growth hormone secretion (GO:0030252) | 2.86122925 |
| 140 | regulation of beta-amyloid formation (GO:1902003) | 2.85898340 |
| 141 | establishment of protein localization to Golgi (GO:0072600) | 2.85605274 |
| 142 | membrane repolarization during action potential (GO:0086011) | 2.84871074 |
| 143 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.83103170 |
| 144 | hormone secretion (GO:0046879) | 2.82756830 |
| 145 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.81045792 |
| 146 | mechanosensory behavior (GO:0007638) | 2.80624468 |
| 147 | positive regulation of dendritic spine development (GO:0060999) | 2.79601643 |
| 148 | potassium ion import (GO:0010107) | 2.78235082 |
| 149 | peptide transport (GO:0015833) | 2.77908010 |
| 150 | neurofilament cytoskeleton organization (GO:0060052) | 2.77023535 |
| 151 | regulation of synaptic plasticity (GO:0048167) | 2.75890792 |
| 152 | long-term memory (GO:0007616) | 2.75352086 |
| 153 | response to ischemia (GO:0002931) | 2.74168513 |
| 154 | cellular response to vitamin D (GO:0071305) | 2.73595514 |
| 155 | cell communication by electrical coupling (GO:0010644) | 2.73535432 |
| 156 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.73501290 |
| 157 | dopamine receptor signaling pathway (GO:0007212) | 2.73488817 |
| 158 | cellular sodium ion homeostasis (GO:0006883) | 2.73063100 |
| 159 | macroautophagy (GO:0016236) | 2.72722385 |
| 160 | behavioral fear response (GO:0001662) | 2.72427838 |
| 161 | behavioral defense response (GO:0002209) | 2.72427838 |
| 162 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.71013023 |
| 163 | synapse organization (GO:0050808) | 2.71012658 |
| 164 | positive regulation of hormone secretion (GO:0046887) | 2.70985432 |
| 165 | establishment of synaptic vesicle localization (GO:0097480) | 2.70358139 |
| 166 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.69926121 |
| 167 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.69417043 |
| 168 | epithelial cell fate commitment (GO:0072148) | 2.69357376 |
| 169 | signal peptide processing (GO:0006465) | 2.67881540 |
| 170 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.67204522 |
| 171 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.65904432 |
| 172 | hormone transport (GO:0009914) | 2.65801136 |
| 173 | neuromuscular process controlling posture (GO:0050884) | 2.63571120 |
| 174 | suckling behavior (GO:0001967) | 2.62844672 |
| 175 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.61876581 |
| 176 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.60682467 |
| 177 | regulation of norepinephrine secretion (GO:0014061) | 2.59860161 |
| 178 | regulation of ARF protein signal transduction (GO:0032012) | 2.59607051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.19558787 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.64663387 |
| 3 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.98949574 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.80140954 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.47361541 |
| 6 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.39164986 |
| 7 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.36714957 |
| 8 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.25071331 |
| 9 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.24635876 |
| 10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.12543411 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.11370845 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.11280000 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.10805659 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.10527168 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.09227616 |
| 16 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.05051057 |
| 17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.04611648 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.99466661 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.96737391 |
| 20 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.91642831 |
| 21 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.90812458 |
| 22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.89976777 |
| 23 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.89448757 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.88411678 |
| 25 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.80193932 |
| 26 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.78018189 |
| 27 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.75514233 |
| 28 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.75089922 |
| 29 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.75044436 |
| 30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.72869489 |
| 31 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.72869489 |
| 32 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.71840878 |
| 33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.65233573 |
| 34 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.60297292 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.60134072 |
| 36 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.59648445 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.54133655 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49263849 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.47722369 |
| 40 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.47019734 |
| 41 | STAT3_23295773_ChIP-Seq_U87_Human | 1.45082376 |
| 42 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.41585558 |
| 43 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.39454032 |
| 44 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38905932 |
| 45 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38318860 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37843161 |
| 47 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37115009 |
| 48 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.35891513 |
| 49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.33287189 |
| 50 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31700100 |
| 51 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.30631201 |
| 52 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.27724033 |
| 53 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.27085686 |
| 54 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.25812902 |
| 55 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.25706157 |
| 56 | AR_19668381_ChIP-Seq_PC3_Human | 1.25419397 |
| 57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22262224 |
| 58 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.20123205 |
| 59 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19484969 |
| 60 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.17847143 |
| 61 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.16809123 |
| 62 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14284589 |
| 63 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13280534 |
| 64 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.12982602 |
| 65 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.12290476 |
| 66 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11291568 |
| 67 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.10862721 |
| 68 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.10451685 |
| 69 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10390457 |
| 70 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.09959842 |
| 71 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.09729329 |
| 72 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.09171144 |
| 73 | VDR_22108803_ChIP-Seq_LS180_Human | 1.08116253 |
| 74 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07438634 |
| 75 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.07387548 |
| 76 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.06769253 |
| 77 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06660731 |
| 78 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.06569964 |
| 79 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.06059916 |
| 80 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.05956162 |
| 81 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.05918014 |
| 82 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04761002 |
| 83 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04761002 |
| 84 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.04187408 |
| 85 | AR_25329375_ChIP-Seq_VCAP_Human | 1.02640941 |
| 86 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02604058 |
| 87 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02330990 |
| 88 | P300_19829295_ChIP-Seq_ESCs_Human | 1.02275569 |
| 89 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01460377 |
| 90 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98757471 |
| 91 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.98257382 |
| 92 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.98076892 |
| 93 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.97288093 |
| 94 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.96093909 |
| 95 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.96020667 |
| 96 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95442606 |
| 97 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94132719 |
| 98 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.94101849 |
| 99 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.93947302 |
| 100 | KDM2B_26808549_Chip-Seq_K562_Human | 0.93348463 |
| 101 | FUS_26573619_Chip-Seq_HEK293_Human | 0.92428836 |
| 102 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91793704 |
| 103 | JUN_21703547_ChIP-Seq_K562_Human | 0.91410600 |
| 104 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.90535351 |
| 105 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.90378525 |
| 106 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.90378525 |
| 107 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.89836809 |
| 108 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.89717716 |
| 109 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89532107 |
| 110 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.88491429 |
| 111 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.88251347 |
| 112 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.88237046 |
| 113 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88170869 |
| 114 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.87851027 |
| 115 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.87680103 |
| 116 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.87615269 |
| 117 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.87538749 |
| 118 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.87529930 |
| 119 | KDM2B_26808549_Chip-Seq_REH_Human | 0.86880973 |
| 120 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86205111 |
| 121 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84758746 |
| 122 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.83772481 |
| 123 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.82758264 |
| 124 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82752993 |
| 125 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.81410358 |
| 126 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.80711101 |
| 127 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.80132748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003283_abnormal_digestive_organ | 4.33544494 |
| 2 | MP0002909_abnormal_adrenal_gland | 4.27144024 |
| 3 | MP0009780_abnormal_chondrocyte_physiolo | 3.90098848 |
| 4 | MP0002877_abnormal_melanocyte_morpholog | 3.85219554 |
| 5 | MP0000013_abnormal_adipose_tissue | 3.52348980 |
| 6 | MP0002693_abnormal_pancreas_physiology | 3.38891202 |
| 7 | MP0004043_abnormal_pH_regulation | 3.34252827 |
| 8 | MP0004859_abnormal_synaptic_plasticity | 3.11998565 |
| 9 | MP0001944_abnormal_pancreas_morphology | 3.07193395 |
| 10 | MP0010386_abnormal_urinary_bladder | 2.80210249 |
| 11 | MP0004270_analgesia | 2.79635639 |
| 12 | MP0005379_endocrine/exocrine_gland_phen | 2.78859781 |
| 13 | MP0003183_abnormal_peptide_metabolism | 2.69845984 |
| 14 | MP0003195_calcinosis | 2.64841266 |
| 15 | MP0000678_abnormal_parathyroid_gland | 2.53812577 |
| 16 | MP0003635_abnormal_synaptic_transmissio | 2.35676662 |
| 17 | MP0003122_maternal_imprinting | 2.33449188 |
| 18 | MP0005645_abnormal_hypothalamus_physiol | 2.20473639 |
| 19 | MP0005646_abnormal_pituitary_gland | 2.18306268 |
| 20 | MP0002837_dystrophic_cardiac_calcinosis | 2.09244037 |
| 21 | MP0006072_abnormal_retinal_apoptosis | 1.97682476 |
| 22 | MP0002078_abnormal_glucose_homeostasis | 1.91981656 |
| 23 | MP0003880_abnormal_central_pattern | 1.88280747 |
| 24 | MP0000778_abnormal_nervous_system | 1.85439050 |
| 25 | MP0005220_abnormal_exocrine_pancreas | 1.84354635 |
| 26 | MP0002734_abnormal_mechanical_nocicepti | 1.77560307 |
| 27 | MP0002063_abnormal_learning/memory/cond | 1.74296655 |
| 28 | MP0000003_abnormal_adipose_tissue | 1.70251361 |
| 29 | MP0008961_abnormal_basal_metabolism | 1.65352275 |
| 30 | MP0002234_abnormal_pharynx_morphology | 1.65246195 |
| 31 | MP0002572_abnormal_emotion/affect_behav | 1.64788405 |
| 32 | MP0002064_seizures | 1.62308951 |
| 33 | MP0009745_abnormal_behavioral_response | 1.60573686 |
| 34 | MP0002638_abnormal_pupillary_reflex | 1.59644192 |
| 35 | MP0002736_abnormal_nociception_after | 1.58237000 |
| 36 | MP0001986_abnormal_taste_sensitivity | 1.56867307 |
| 37 | MP0008877_abnormal_DNA_methylation | 1.55375210 |
| 38 | MP0002272_abnormal_nervous_system | 1.53948201 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.50525496 |
| 40 | MP0000569_abnormal_digit_pigmentation | 1.49715675 |
| 41 | MP0003787_abnormal_imprinting | 1.49548635 |
| 42 | MP0002733_abnormal_thermal_nociception | 1.48575907 |
| 43 | MP0001905_abnormal_dopamine_level | 1.48271036 |
| 44 | MP0004885_abnormal_endolymph | 1.43302411 |
| 45 | MP0001501_abnormal_sleep_pattern | 1.38484563 |
| 46 | MP0001765_abnormal_ion_homeostasis | 1.36216572 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.35401397 |
| 48 | MP0003879_abnormal_hair_cell | 1.34795986 |
| 49 | MP0001529_abnormal_vocalization | 1.33676251 |
| 50 | MP0000631_abnormal_neuroendocrine_gland | 1.30020407 |
| 51 | MP0009046_muscle_twitch | 1.28587676 |
| 52 | MP0001970_abnormal_pain_threshold | 1.27927101 |
| 53 | MP0001188_hyperpigmentation | 1.27498519 |
| 54 | MP0003953_abnormal_hormone_level | 1.25839649 |
| 55 | MP0005535_abnormal_body_temperature | 1.24373769 |
| 56 | MP0002896_abnormal_bone_mineralization | 1.21804082 |
| 57 | MP0004145_abnormal_muscle_electrophysio | 1.21290121 |
| 58 | MP0000955_abnormal_spinal_cord | 1.17109708 |
| 59 | MP0004264_abnormal_extraembryonic_tissu | 1.15925954 |
| 60 | MP0002557_abnormal_social/conspecific_i | 1.15677951 |
| 61 | MP0000462_abnormal_digestive_system | 1.14109231 |
| 62 | MP0003631_nervous_system_phenotype | 1.13705846 |
| 63 | MP0002876_abnormal_thyroid_physiology | 1.11395647 |
| 64 | MP0002928_abnormal_bile_duct | 1.11043424 |
| 65 | MP0001486_abnormal_startle_reflex | 1.09848911 |
| 66 | MP0008569_lethality_at_weaning | 1.06064458 |
| 67 | MP0002067_abnormal_sensory_capabilities | 1.04779117 |
| 68 | MP0006276_abnormal_autonomic_nervous | 1.04598680 |
| 69 | MP0002184_abnormal_innervation | 1.04594999 |
| 70 | MP0004811_abnormal_neuron_physiology | 1.04322432 |
| 71 | MP0004742_abnormal_vestibular_system | 1.04212427 |
| 72 | MP0003868_abnormal_feces_composition | 1.02135720 |
| 73 | MP0002152_abnormal_brain_morphology | 1.01506224 |
| 74 | MP0005423_abnormal_somatic_nervous | 1.01499989 |
| 75 | MP0001968_abnormal_touch/_nociception | 0.99677832 |
| 76 | MP0003329_amyloid_beta_deposits | 0.98047199 |
| 77 | MP0002735_abnormal_chemical_nociception | 0.96001456 |
| 78 | MP0001984_abnormal_olfaction | 0.95175531 |
| 79 | MP0001299_abnormal_eye_distance/ | 0.94803252 |
| 80 | MP0003690_abnormal_glial_cell | 0.94258312 |
| 81 | MP0003959_abnormal_lean_body | 0.93362657 |
| 82 | MP0002069_abnormal_eating/drinking_beha | 0.91260782 |
| 83 | MP0003633_abnormal_nervous_system | 0.89087993 |
| 84 | MP0003300_gastrointestinal_ulcer | 0.88798928 |
| 85 | MP0004142_abnormal_muscle_tone | 0.88198059 |
| 86 | MP0005386_behavior/neurological_phenoty | 0.87740344 |
| 87 | MP0004924_abnormal_behavior | 0.87740344 |
| 88 | MP0002163_abnormal_gland_morphology | 0.87228404 |
| 89 | MP0004858_abnormal_nervous_system | 0.87153474 |
| 90 | MP0003632_abnormal_nervous_system | 0.86657567 |
| 91 | MP0004510_myositis | 0.86050184 |
| 92 | MP0001440_abnormal_grooming_behavior | 0.85660873 |
| 93 | MP0003119_abnormal_digestive_system | 0.85369658 |
| 94 | MP0005253_abnormal_eye_physiology | 0.84078125 |
| 95 | MP0002066_abnormal_motor_capabilities/c | 0.82901678 |
| 96 | MP0005448_abnormal_energy_balance | 0.81802549 |
| 97 | MP0002882_abnormal_neuron_morphology | 0.81687076 |
| 98 | MP0002229_neurodegeneration | 0.80374237 |
| 99 | MP0001963_abnormal_hearing_physiology | 0.78383636 |
| 100 | MP0003045_fibrosis | 0.76666792 |
| 101 | MP0001270_distended_abdomen | 0.76665084 |
| 102 | MP0005310_abnormal_salivary_gland | 0.76421564 |
| 103 | MP0008872_abnormal_physiological_respon | 0.76298490 |
| 104 | MP0000639_abnormal_adrenal_gland | 0.76003883 |
| 105 | MP0005187_abnormal_penis_morphology | 0.75264735 |
| 106 | MP0000613_abnormal_salivary_gland | 0.75087360 |
| 107 | MP0002752_abnormal_somatic_nervous | 0.74374332 |
| 108 | MP0000230_abnormal_systemic_arterial | 0.73460217 |
| 109 | MP0000920_abnormal_myelination | 0.72615869 |
| 110 | MP0004085_abnormal_heartbeat | 0.71575700 |
| 111 | MP0003123_paternal_imprinting | 0.70786167 |
| 112 | MP0005058_abnormal_lysosome_morphology | 0.68498425 |
| 113 | MP0001664_abnormal_digestion | 0.68107674 |
| 114 | MP0001177_atelectasis | 0.67666632 |
| 115 | MP0003121_genomic_imprinting | 0.67396661 |
| 116 | MP0002102_abnormal_ear_morphology | 0.66884973 |
| 117 | MP0002822_catalepsy | 0.66541548 |
| 118 | MP0005551_abnormal_eye_electrophysiolog | 0.66270096 |
| 119 | MP0002090_abnormal_vision | 0.65341065 |
| 120 | MP0005375_adipose_tissue_phenotype | 0.64977968 |
| 121 | MP0003634_abnormal_glial_cell | 0.64603962 |
| 122 | MP0002082_postnatal_lethality | 0.63656026 |
| 123 | MP0010770_preweaning_lethality | 0.63656026 |
| 124 | MP0004133_heterotaxia | 0.63399731 |
| 125 | MP0001485_abnormal_pinna_reflex | 0.61319104 |
| 126 | MP0010769_abnormal_survival | 0.60265572 |
| 127 | MP0010768_mortality/aging | 0.57065378 |
| 128 | MP0000026_abnormal_inner_ear | 0.55935926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 7.11176777 |
| 2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 7.04273261 |
| 3 | Hypoglycemic seizures (HP:0002173) | 6.12008619 |
| 4 | Symptomatic seizures (HP:0011145) | 5.65284407 |
| 5 | Limb dystonia (HP:0002451) | 5.24561973 |
| 6 | Hypoglycemic coma (HP:0001325) | 4.69687910 |
| 7 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.60882391 |
| 8 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.57900952 |
| 9 | Hyperglycemia (HP:0003074) | 4.34072761 |
| 10 | Visual hallucinations (HP:0002367) | 4.21867225 |
| 11 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.21818136 |
| 12 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.21818136 |
| 13 | Pancreatic islet-cell hyperplasia (HP:0004510) | 4.18160069 |
| 14 | Action tremor (HP:0002345) | 4.11041971 |
| 15 | Large for gestational age (HP:0001520) | 4.07633354 |
| 16 | Decreased circulating renin level (HP:0003351) | 3.83304935 |
| 17 | Ketoacidosis (HP:0001993) | 3.79573976 |
| 18 | Agitation (HP:0000713) | 3.75412801 |
| 19 | Late onset (HP:0003584) | 3.51894302 |
| 20 | Papilledema (HP:0001085) | 3.42105412 |
| 21 | Abnormal pancreas size (HP:0012094) | 3.36773609 |
| 22 | Ankle clonus (HP:0011448) | 3.34439885 |
| 23 | EEG with generalized epileptiform discharges (HP:0011198) | 3.20118079 |
| 24 | Abnormal eating behavior (HP:0100738) | 3.14533572 |
| 25 | Epileptiform EEG discharges (HP:0011182) | 3.14363838 |
| 26 | Drooling (HP:0002307) | 3.12578745 |
| 27 | Mutism (HP:0002300) | 3.12378512 |
| 28 | Akinesia (HP:0002304) | 3.11742220 |
| 29 | Polyphagia (HP:0002591) | 3.11562444 |
| 30 | Hypsarrhythmia (HP:0002521) | 3.10397006 |
| 31 | Focal motor seizures (HP:0011153) | 3.09120128 |
| 32 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.06999164 |
| 33 | Mucopolysacchariduria (HP:0008155) | 3.06999164 |
| 34 | Hyperparathyroidism (HP:0000843) | 3.03741496 |
| 35 | Hyperventilation (HP:0002883) | 2.99101250 |
| 36 | Broad-based gait (HP:0002136) | 2.98566256 |
| 37 | Hypokalemia (HP:0002900) | 2.95179806 |
| 38 | Torticollis (HP:0000473) | 2.92071895 |
| 39 | Diplopia (HP:0000651) | 2.90119579 |
| 40 | Abnormality of binocular vision (HP:0011514) | 2.90119579 |
| 41 | Dysostosis multiplex (HP:0000943) | 2.89887878 |
| 42 | Excessive salivation (HP:0003781) | 2.89701154 |
| 43 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.88010962 |
| 44 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.88010962 |
| 45 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.88010962 |
| 46 | Spastic gait (HP:0002064) | 2.74931660 |
| 47 | Pheochromocytoma (HP:0002666) | 2.73498907 |
| 48 | Atonic seizures (HP:0010819) | 2.72119085 |
| 49 | Retinal atrophy (HP:0001105) | 2.72046310 |
| 50 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.64218179 |
| 51 | Abnormality of renin-angiotensin system (HP:0000847) | 2.64089401 |
| 52 | Unilateral renal agenesis (HP:0000122) | 2.63466000 |
| 53 | Menstrual irregularities (HP:0000858) | 2.62405264 |
| 54 | Hypercortisolism (HP:0001578) | 2.54086917 |
| 55 | Abnormality of the corticospinal tract (HP:0002492) | 2.52001646 |
| 56 | Intention tremor (HP:0002080) | 2.51160452 |
| 57 | Osteomalacia (HP:0002749) | 2.51110383 |
| 58 | Status epilepticus (HP:0002133) | 2.49651985 |
| 59 | Absence seizures (HP:0002121) | 2.46516389 |
| 60 | Focal dystonia (HP:0004373) | 2.44432735 |
| 61 | Insulin resistance (HP:0000855) | 2.44290990 |
| 62 | Depression (HP:0000716) | 2.43952306 |
| 63 | Sleep apnea (HP:0010535) | 2.43099153 |
| 64 | Prominent metopic ridge (HP:0005487) | 2.42980630 |
| 65 | Increased circulating renin level (HP:0000848) | 2.42849495 |
| 66 | Abnormality of potassium homeostasis (HP:0011042) | 2.40983530 |
| 67 | Epileptic encephalopathy (HP:0200134) | 2.39193397 |
| 68 | Neuroendocrine neoplasm (HP:0100634) | 2.34359023 |
| 69 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.32021212 |
| 70 | Urinary urgency (HP:0000012) | 2.31329961 |
| 71 | Postural instability (HP:0002172) | 2.31070078 |
| 72 | Dysdiadochokinesis (HP:0002075) | 2.29603526 |
| 73 | Focal seizures (HP:0007359) | 2.29448540 |
| 74 | Poor eye contact (HP:0000817) | 2.27112224 |
| 75 | Dysmetria (HP:0001310) | 2.24181931 |
| 76 | Absent speech (HP:0001344) | 2.23675193 |
| 77 | Anxiety (HP:0000739) | 2.22659834 |
| 78 | Amblyopia (HP:0000646) | 2.22125681 |
| 79 | Restlessness (HP:0000711) | 2.21161702 |
| 80 | Hyperkalemia (HP:0002153) | 2.20601182 |
| 81 | Craniofacial dystonia (HP:0012179) | 2.20468167 |
| 82 | Fetal akinesia sequence (HP:0001989) | 2.16328972 |
| 83 | Dialeptic seizures (HP:0011146) | 2.16143527 |
| 84 | Conjugated hyperbilirubinemia (HP:0002908) | 2.15919054 |
| 85 | Diminished movement (HP:0002374) | 2.14376524 |
| 86 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.13457214 |
| 87 | Failure to thrive in infancy (HP:0001531) | 2.12858862 |
| 88 | Hyperphosphatemia (HP:0002905) | 2.12566764 |
| 89 | Congenital glaucoma (HP:0001087) | 2.12513796 |
| 90 | Genetic anticipation (HP:0003743) | 2.12190842 |
| 91 | Generalized tonic-clonic seizures (HP:0002069) | 2.12085428 |
| 92 | Cortical visual impairment (HP:0100704) | 2.10434387 |
| 93 | Supranuclear gaze palsy (HP:0000605) | 2.10398236 |
| 94 | Dysautonomia (HP:0002459) | 2.10126325 |
| 95 | Abnormality of the metopic suture (HP:0005556) | 2.09756222 |
| 96 | Hyperactive renin-angiotensin system (HP:0000841) | 2.06836206 |
| 97 | Impaired smooth pursuit (HP:0007772) | 2.05240741 |
| 98 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.04938725 |
| 99 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.04938725 |
| 100 | Gait imbalance (HP:0002141) | 2.03314690 |
| 101 | Neoplasm of the heart (HP:0100544) | 2.02789353 |
| 102 | Poor suck (HP:0002033) | 2.02588369 |
| 103 | Macroorchidism (HP:0000053) | 2.01761290 |
| 104 | Bradykinesia (HP:0002067) | 1.99080151 |
| 105 | Gaze-evoked nystagmus (HP:0000640) | 1.98141636 |
| 106 | Truncal ataxia (HP:0002078) | 1.97832981 |
| 107 | Spastic tetraplegia (HP:0002510) | 1.95960016 |
| 108 | Adrenal overactivity (HP:0002717) | 1.95341446 |
| 109 | Hypomagnesemia (HP:0002917) | 1.94832323 |
| 110 | Generalized myoclonic seizures (HP:0002123) | 1.94597092 |
| 111 | Abnormal social behavior (HP:0012433) | 1.91037325 |
| 112 | Impaired social interactions (HP:0000735) | 1.91037325 |
| 113 | Hypothermia (HP:0002045) | 1.89063346 |
| 114 | Hypotension (HP:0002615) | 1.88766523 |
| 115 | Generalized aminoaciduria (HP:0002909) | 1.88740659 |
| 116 | Postural tremor (HP:0002174) | 1.87614932 |
| 117 | Impaired vibratory sensation (HP:0002495) | 1.87315131 |
| 118 | Inability to walk (HP:0002540) | 1.85124843 |
| 119 | Amyotrophic lateral sclerosis (HP:0007354) | 1.84676797 |
| 120 | Lower limb muscle weakness (HP:0007340) | 1.84392572 |
| 121 | Progressive cerebellar ataxia (HP:0002073) | 1.82315980 |
| 122 | Hemiparesis (HP:0001269) | 1.81494841 |
| 123 | Ketosis (HP:0001946) | 1.80110870 |
| 124 | Type II lissencephaly (HP:0007260) | 1.78161151 |
| 125 | Clonus (HP:0002169) | 1.77421329 |
| 126 | Abnormality of the fovea (HP:0000493) | 1.76769830 |
| 127 | Exocrine pancreatic insufficiency (HP:0001738) | 1.76524962 |
| 128 | Muscular hypotonia of the trunk (HP:0008936) | 1.76332673 |
| 129 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.75737945 |
| 130 | Hypoplasia of the fovea (HP:0007750) | 1.75737945 |
| 131 | Hemiplegia (HP:0002301) | 1.75395299 |
| 132 | Chronic bronchitis (HP:0004469) | 1.74858739 |
| 133 | Inappropriate behavior (HP:0000719) | 1.73507925 |
| 134 | Limb hypertonia (HP:0002509) | 1.73082359 |
| 135 | Global brain atrophy (HP:0002283) | 1.73021256 |
| 136 | Hypophosphatemia (HP:0002148) | 1.72485204 |
| 137 | Hyperthyroidism (HP:0000836) | 1.72444107 |
| 138 | Growth hormone excess (HP:0000845) | 1.72151821 |
| 139 | Progressive neurologic deterioration (HP:0002344) | 1.71204796 |
| 140 | Abnormality of the intrinsic pathway (HP:0010989) | 1.68341710 |
| 141 | Megalencephaly (HP:0001355) | 1.67475081 |
| 142 | Gout (HP:0001997) | 1.67082655 |
| 143 | Cerebral inclusion bodies (HP:0100314) | 1.65645791 |
| 144 | Neurofibrillary tangles (HP:0002185) | 1.65111248 |
| 145 | Testicular neoplasm (HP:0010788) | 1.64810922 |
| 146 | Abdominal distention (HP:0003270) | 1.64161088 |
| 147 | Febrile seizures (HP:0002373) | 1.64149015 |
| 148 | Resting tremor (HP:0002322) | 1.64138860 |
| 149 | Generalized hyperpigmentation (HP:0007440) | 1.64117299 |
| 150 | Hyperphosphaturia (HP:0003109) | 1.64047326 |
| 151 | Hypocalcemia (HP:0002901) | 1.63684410 |
| 152 | Myokymia (HP:0002411) | 1.62986285 |
| 153 | Ventricular fibrillation (HP:0001663) | 1.61751227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 5.91294563 |
| 2 | PASK | 4.17965608 |
| 3 | MAPK15 | 3.83699221 |
| 4 | NTRK3 | 3.83492710 |
| 5 | PRKD3 | 3.40249247 |
| 6 | TAOK3 | 3.01080299 |
| 7 | MAP3K2 | 2.86757488 |
| 8 | HIPK2 | 2.66286188 |
| 9 | WNK3 | 2.52558543 |
| 10 | UHMK1 | 2.26842190 |
| 11 | NTRK1 | 2.24630166 |
| 12 | CAMKK2 | 2.17470811 |
| 13 | PHKG1 | 1.99695871 |
| 14 | PHKG2 | 1.99695871 |
| 15 | FRK | 1.98739596 |
| 16 | MAP3K1 | 1.90842010 |
| 17 | SIK2 | 1.87959761 |
| 18 | MAP3K9 | 1.84883375 |
| 19 | WNK4 | 1.80030602 |
| 20 | SCYL2 | 1.75055403 |
| 21 | MAP3K4 | 1.69241464 |
| 22 | PINK1 | 1.58558348 |
| 23 | CDC42BPA | 1.47078551 |
| 24 | PRKCH | 1.41074937 |
| 25 | CAMKK1 | 1.38503791 |
| 26 | EPHA4 | 1.38030819 |
| 27 | DYRK2 | 1.36254840 |
| 28 | PDGFRA | 1.35143231 |
| 29 | DAPK2 | 1.25998256 |
| 30 | PAK6 | 1.24767152 |
| 31 | KSR2 | 1.22619000 |
| 32 | MINK1 | 1.19909507 |
| 33 | MAP2K7 | 1.18054290 |
| 34 | PAK3 | 1.16476075 |
| 35 | LATS2 | 1.14616706 |
| 36 | BCR | 1.07489844 |
| 37 | MARK1 | 1.06097188 |
| 38 | CDK5 | 1.05217557 |
| 39 | PRKD2 | 1.03190937 |
| 40 | OXSR1 | 1.02281529 |
| 41 | PTK2 | 1.01211173 |
| 42 | GRK5 | 0.95989929 |
| 43 | TYRO3 | 0.95762477 |
| 44 | FER | 0.92496883 |
| 45 | FLT3 | 0.92334952 |
| 46 | RET | 0.91345801 |
| 47 | CDK19 | 0.88992983 |
| 48 | PNCK | 0.88171936 |
| 49 | EPHA3 | 0.88161547 |
| 50 | WNK1 | 0.87904312 |
| 51 | NTRK2 | 0.85919371 |
| 52 | AKT3 | 0.85576832 |
| 53 | ERN1 | 0.79018480 |
| 54 | PRKCG | 0.78117500 |
| 55 | MAP2K4 | 0.77200054 |
| 56 | FGFR2 | 0.76238844 |
| 57 | CAMK2D | 0.75787281 |
| 58 | CDK14 | 0.73549188 |
| 59 | CDK18 | 0.73335287 |
| 60 | CAMK2B | 0.72701012 |
| 61 | CDK15 | 0.72599044 |
| 62 | BRSK1 | 0.70711597 |
| 63 | IRAK1 | 0.70631585 |
| 64 | PRKCE | 0.70184120 |
| 65 | DAPK1 | 0.69695260 |
| 66 | MARK2 | 0.67374326 |
| 67 | DYRK1B | 0.67346134 |
| 68 | LMTK2 | 0.66680934 |
| 69 | BRSK2 | 0.66110035 |
| 70 | TNIK | 0.65242866 |
| 71 | PKN1 | 0.64937328 |
| 72 | MAP2K6 | 0.64886033 |
| 73 | PTK6 | 0.64509068 |
| 74 | PRKCZ | 0.63907151 |
| 75 | DYRK1A | 0.62886035 |
| 76 | BRAF | 0.62571819 |
| 77 | CDK11A | 0.62336860 |
| 78 | CSNK1G3 | 0.62305731 |
| 79 | ALK | 0.61903814 |
| 80 | CAMK2A | 0.60515999 |
| 81 | SGK494 | 0.60214994 |
| 82 | SGK223 | 0.60214994 |
| 83 | ERBB3 | 0.59892689 |
| 84 | IRAK2 | 0.59662536 |
| 85 | TAOK1 | 0.59053227 |
| 86 | RIPK1 | 0.57331949 |
| 87 | TRIB3 | 0.57199354 |
| 88 | CSNK1G1 | 0.56256908 |
| 89 | PIK3CG | 0.54251913 |
| 90 | IRAK3 | 0.53354929 |
| 91 | CASK | 0.53271250 |
| 92 | ARAF | 0.51560504 |
| 93 | BRD4 | 0.51379533 |
| 94 | FES | 0.50382392 |
| 95 | MAPK13 | 0.49619651 |
| 96 | STK38 | 0.49222935 |
| 97 | CAMK4 | 0.48839176 |
| 98 | CAMK2G | 0.48729158 |
| 99 | TESK1 | 0.47649635 |
| 100 | PRKAA1 | 0.46483342 |
| 101 | KSR1 | 0.46109866 |
| 102 | SGK2 | 0.45736863 |
| 103 | ADRBK2 | 0.45398127 |
| 104 | STK39 | 0.45308836 |
| 105 | CAMK1 | 0.44753530 |
| 106 | MAP3K12 | 0.44463750 |
| 107 | EIF2AK3 | 0.44344005 |
| 108 | PRPF4B | 0.44136763 |
| 109 | CAMK1G | 0.43993160 |
| 110 | STK11 | 0.43311868 |
| 111 | SGK1 | 0.42817667 |
| 112 | RPS6KA3 | 0.42261126 |
| 113 | RPS6KA2 | 0.42111216 |
| 114 | JAK2 | 0.41771534 |
| 115 | CSNK1E | 0.41088854 |
| 116 | BMPR2 | 0.41005215 |
| 117 | PRKG1 | 0.39621509 |
| 118 | CSNK1A1 | 0.39439627 |
| 119 | MAPK12 | 0.39183581 |
| 120 | MAPK10 | 0.38748824 |
| 121 | PRKACG | 0.38283249 |
| 122 | RIPK4 | 0.37985130 |
| 123 | SGK3 | 0.37690355 |
| 124 | PRKACA | 0.36912936 |
| 125 | NEK6 | 0.36560195 |
| 126 | PRKD1 | 0.36247411 |
| 127 | CSNK1A1L | 0.35148002 |
| 128 | PDPK1 | 0.34309781 |
| 129 | FYN | 0.33646345 |
| 130 | PRKCI | 0.32955258 |
| 131 | PRKCA | 0.32583358 |
| 132 | LIMK1 | 0.32233626 |
| 133 | PLK2 | 0.32139633 |
| 134 | CSNK1G2 | 0.32120974 |
| 135 | NME1 | 0.31999952 |
| 136 | TRIM28 | 0.31151714 |
| 137 | PRKCB | 0.28683522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.61636470 |
| 2 | Insulin secretion_Homo sapiens_hsa04911 | 3.59908470 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.12682016 |
| 4 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.52524293 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.33283435 |
| 6 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.18950381 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.18447927 |
| 8 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.16195726 |
| 9 | Cocaine addiction_Homo sapiens_hsa05030 | 2.01345987 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.98739208 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 1.97201673 |
| 12 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.95192683 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 1.94528332 |
| 14 | Circadian entrainment_Homo sapiens_hsa04713 | 1.85758938 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.83882801 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.81437819 |
| 17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.77589803 |
| 18 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.72140349 |
| 19 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.71265286 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.70208653 |
| 21 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.68371595 |
| 22 | Nicotine addiction_Homo sapiens_hsa05033 | 1.67861380 |
| 23 | Morphine addiction_Homo sapiens_hsa05032 | 1.60122946 |
| 24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.60050516 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.50094626 |
| 26 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.49369888 |
| 27 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.38182747 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.37276012 |
| 29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.36478539 |
| 30 | Olfactory transduction_Homo sapiens_hsa04740 | 1.25968596 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.21905274 |
| 32 | Phototransduction_Homo sapiens_hsa04744 | 1.18522767 |
| 33 | Circadian rhythm_Homo sapiens_hsa04710 | 1.15563071 |
| 34 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.14983218 |
| 35 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14822530 |
| 36 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.13002912 |
| 37 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.11199827 |
| 38 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.10574567 |
| 39 | Salivary secretion_Homo sapiens_hsa04970 | 1.10242423 |
| 40 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.10222403 |
| 41 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.09310181 |
| 42 | Axon guidance_Homo sapiens_hsa04360 | 1.04055349 |
| 43 | Long-term depression_Homo sapiens_hsa04730 | 1.03016753 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 0.97856117 |
| 45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94100823 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.92890053 |
| 47 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.90788102 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.89584098 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88262647 |
| 50 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87356849 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86408944 |
| 52 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.85855855 |
| 53 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.85173052 |
| 54 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84921576 |
| 55 | Gap junction_Homo sapiens_hsa04540 | 0.84154857 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 0.81021267 |
| 57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.79943433 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.78921312 |
| 59 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.78699106 |
| 60 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76937562 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 0.76738213 |
| 62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72083039 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72029134 |
| 64 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69755837 |
| 65 | Melanogenesis_Homo sapiens_hsa04916 | 0.69733969 |
| 66 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67963472 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.65217986 |
| 68 | Alcoholism_Homo sapiens_hsa05034 | 0.63499707 |
| 69 | Glioma_Homo sapiens_hsa05214 | 0.61884517 |
| 70 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61755556 |
| 71 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.61123625 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60090703 |
| 73 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59267255 |
| 74 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58959166 |
| 75 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.57977067 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55327437 |
| 77 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52809165 |
| 78 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.52708114 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52264691 |
| 80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51761998 |
| 81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.50487129 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.49291261 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.47312400 |
| 84 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46708178 |
| 85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.46665357 |
| 86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.46614867 |
| 87 | ABC transporters_Homo sapiens_hsa02010 | 0.44980130 |
| 88 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44160647 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43611344 |
| 90 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43086043 |
| 91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41684290 |
| 92 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.40701292 |
| 93 | Other glycan degradation_Homo sapiens_hsa00511 | 0.40309438 |
| 94 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.39946373 |
| 95 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.38445117 |
| 96 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.38021463 |
| 97 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.36039475 |
| 98 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.35401715 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35095713 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34892410 |
| 101 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.34620921 |
| 102 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.33190410 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32582859 |
| 104 | Parkinsons disease_Homo sapiens_hsa05012 | 0.32533451 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32403731 |
| 106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32300667 |
| 107 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30353779 |
| 108 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.29577251 |
| 109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.29222866 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.28649801 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28499540 |
| 112 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.27643474 |
| 113 | Histidine metabolism_Homo sapiens_hsa00340 | 0.26897982 |
| 114 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.26418294 |
| 115 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.26343370 |
| 116 | Tight junction_Homo sapiens_hsa04530 | 0.26113485 |
| 117 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.25780303 |
| 118 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25635274 |
| 119 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25600513 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25337133 |
| 121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.24370776 |
| 122 | Alzheimers disease_Homo sapiens_hsa05010 | 0.24089288 |

